Form 4 for MNST Monster Beverage
Accepted 2022-03-16 00:00:00 ET · period of report 2022-02-02 · accession 0001567619-22-007092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-16 | 2022-03-14 | MNST | SACKS RODNEY C | COB, Co-CEO, Dir | A - Grant | $0.00 | +78.6K | 145.9K | +117% | $0 |
| D | 2022-03-16 | 2022-03-14 | MNST | SACKS RODNEY C | COB, Co-CEO, Dir | F - Tax | $73.23 | -69.8K | 138.2K | -34% | -$5.11M |
| D | 2022-03-16 | 2022-03-14 | MNST | SACKS RODNEY C | COB, Co-CEO, Dir | M - OptEx | — | +62.2K | 208.0K | +43% | — |
| DMI | 2022-03-16 | 2022-02-02 | MNST | SACKS RODNEY C | COB, Co-CEO, Dir | G - Gift | $0.00 | -690.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | A | A | 64,084 | $0.00 | 131,304 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-14 | F | D | 69,825 | $73.23 | 138,224 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-14 | M | A | 62,195 | — | 208,049 | D | — | — | (F3) Sum of all restricted stock units vested on March 14, 2022. (F4) Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date. Accordingly, these restricted stock units were settled in shares of common stock. |
| 4 | Common | Common Stock | 2022-03-14 | A | A | 14,550 | $0.00 | 145,854 | D | — | — | (F2) Share amount reflects that portion of the reporting person's annual incentive award for the 2021 fiscal year granted under the Monster Beverage Corporation 2020 Omnibus Incentive Plan (the "2020 Omnibus Incentive Plan") paid upon the achievement of performance-based vesting criteria applicable to such portion of the award that is payable in shares of the Company's common stock, achievement of which was certified by the Compensation Committee. The shares underlying the award are immediately vested. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 48,600 | $0.00 | 0 | I By Hilrod Holdings XXI, L.P. | $59.67 · — to 2029-03-14 | 48,600 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 88,000 | $0.00 | 0 | I By Hilrod Holdings XXI, L.P. | $58.73 · — to 2028-03-14 | 88,000 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 88,000 | $0.00 | 0 | I By Hilrod Holdings XX, L.P. | $58.73 · — to 2028-03-14 | 88,000 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 100,751 | $0.00 | 0 | I By Hilrod Holdings XXI, L.P. | $46.27 · — to 2027-03-14 | 100,751 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 100,752 | $0.00 | 0 | I By Hilrod Holdings XX, L.P. | $46.27 · — to 2027-03-14 | 100,752 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 107,736 | $0.00 | 0 | I By Hilrod Holdings XXI, L.P. | $43.99 · — to 2026-03-14 | 107,736 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 107,736 | $0.00 | 0 | I By Hilrod Holdings XX, L.P. | $43.99 · — to 2026-03-14 | 107,736 Common stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2022-02-02 | G | D | 48,600 | $0.00 | 0 | I By Hilrod Holdings XX, L.P. | $59.67 · — to 2029-03-14 | 48,600 Common Stock | (F5) Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. (F6) The options are currently vested. |